.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
Live at RSNA 2025 with Dr. Roger Yang
ScreenPoint Medical's interview with Dr. Roger Yang, President of University Radiology and Clinical Associate Professor of Radiology at Rutgers.
Live at RSNA 2025 with Dr. Rachel Brem
ScreenPoint Medical's interview with Dr. Rachel Brem, Director of Breast Imaging and Intervention at The George Washington University School of Medicine.
.png)
I tell my story to change yours - with Karin Boxem
Karin Boxem shares her fight with breast cancer and the mission that animates her advocacy.
.png)
ScreenPoint Medical highlights Transpara regulatory clearances
Transpara Detection can be used as decision support, as an independent second reader, to optimize workflow, and more.
.png)
AI increases breast cancer detection – with Dr. Cathy Keller
Dr. Cathy Keller discusses how breast AI is used to improve breast screening accuracy and offers key recommendations for awareness and action.
.png)
AI can act as your second reader for breast cancer screening programmes
As leading breast cancer screening programmes look to adapt and advance, Breast AI may serve as a lifeline to better workflow and improved health outcomes.